CRP and Crohn disease: It is therefore of interest that anti-interleukin-6 receptor antibody has been shown to be clinically beneficial for the treatment of arthritis and Crohn's disease and its action is associated with the suppression of C-reactive protein (Nishimoto et al, 2004; Ito et al, 2004).